当日，默沙东宣布，引进翰森制药的口服小分子GLP-1受体激动剂HS-10535，需要支付1.12亿美元的首付款，以及最高19亿美元的里程碑款。 就在1月9日，海外一家biotech公司Verdiva ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

Dan Monahan, the exec who led Otsuka’s commercialization of Rexulti and Abilify Maintena, is taking command of the launch of ...

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

In a notable move, Hims & Hers Health donated $1 million to President-elect Donald Trump’s inauguration fund, signaling its ...

Sharon Mann has lost nearly 30 pounds since starting on Mounjaro, a GLP-1 medication. Dr. Sanjay Gupta reports.

New Anglo/U.S. obesity and cardiometabolic specialist Verdiva Bio Ltd. has launched with a massive $411 million series A and ...

GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

Jonathan Van Ness is taking weight-loss medication to help him deal with a binge-eating disorder that, he says, caused him to ...

1月9日，一家开发针对肥胖症和其他心血管代谢紊乱创新疗法的生物技术公司Verdiva Bio宣布成立，在 超额认购下获得了4.11亿美元的A轮融资。Verdiva的研发管线包含从先为达授权的 ...